Effects of glycemic control on frailty: a multidimensional perspective

References

• Sun H, Saeedi P, Karuranga S, et al. IDF diabetes Atlas: global, regional and country-level diabetes prevalence estimates for 2021 and projections for 2045. Diabet Res Clin Pract. 2022;183:109119.
   PubMed Web of Science ®Google Scholar
• Sinclair AJ, Abdelhafiz AH, Rodríguez-Mañas L. Frailty and sarcopenia - newly emerging and high impact complications of diabetes. J Diabetes Complications. 2017;31:1465–1473.
   PubMed Web of Science ®Google Scholar
• Assar ME, Laosa O, Rodríguez Mañas L. Diabetes and frailty. Curr Opin Clin Nutr Metab Care. 2019;22:52–57.
   PubMed Web of Science ®Google Scholar
• Collard RM, Boter H, Schoevers RA, et al. Prevalence of frailty in community-dwelling older persons: a systematic review. J Am Geriatr Soc. 2012;60:1487–1492.
   PubMed Web of Science ®Google Scholar
• Sinclair AJ, Rodriguez-Mañas L. Diabetes and frailty: two converging conditions? Can J Diabetes. 2016;40:77–83.
   PubMed Web of Science ®Google Scholar
• Liccini AP, Malmstrom TK. Frailty and sarcopenia as predictors of adverse health outcomes in persons with diabetes mellitus. J Am Med Dir Assoc. 2016;17:846–851.
   PubMed Web of Science ®Google Scholar
• Castro-Rodríguez M, Carnicero JA, Garcia-Garcia FJ, et al. Frailty as a major factor in the increased risk of death and disability in older people with diabetes. J Am Med Dir Assoc. 2016;17:949–955.
   PubMed Web of Science ®Google Scholar
• Bergman H, Ferrucci L, Guralnik J, et al. Frailty: an emerging research and clinical paradigm-issues and controversies. J Gerontol A Biol Sci Med Sci. 2009;62A:731–737.
   Google Scholar
• Fried LP, Tangen CM, Walston J, et al. Cardiovascular Health Study Collaborative Research Group. Frailty in older adults: evidence for a phenotype. J Gerontol A Biol Sci Med Sci. 2001;56:M146–156. DOI:10.1093/gerona/56.3.M146
   PubMed Web of Science ®Google Scholar
• Khezrian M, Myint PK, McNeil C, et al. A review of frailty syndrome and its physical, cognitive and emotional domains in the elderly. Geriatrics (Basel). 2017;2:36.
   PubMedGoogle Scholar
• Abdelhafiz AH, Davies PC, Sinclair AJ. Triad of impairment in older people with diabetes-reciprocal relations and clinical implications. Diabet Res Clin Pract. 2020;161:108065.
   PubMed Web of Science ®Google Scholar
• Thein FS, Li Y, Nyunt MSZ, et al. Physical frailty and cognitive impairment is associated with diabetes and adversely impact functional status and mortality. Postgrad Med. 2018;130:561–567.
   PubMed Web of Science ®Google Scholar
• UK Prospective Diabetes Study (UKPDS) Group. Intensive blood glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet. 1998;352:837–853.
   PubMed Web of Science ®Google Scholar
• The ADVANCE Collaborative Group. Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes. N Engl J Med. 2008;358:2560–2572.
   PubMed Web of Science ®Google Scholar
• The ACCORD Study Group. Effects of intensive glucose lowering in type 2 diabetes. N Engl J Med. 2008;358:2545–2559.
   PubMed Web of Science ®Google Scholar
• The VADT Investigators. Glucose control and vascular complications in veterans with type 2 diabetes. N Engl J Med. 2009;360:129–139.
   PubMed Web of Science ®Google Scholar
• Holman RR, Paul SK, Bethel MA, et al. 10-Years follow-up of intensive glucose control in type 2 diabetes. N Engl J Med. 2008;359:1577–1589.
   PubMed Web of Science ®Google Scholar
• Hajjar I, Quach L, Yang F, et al. Hypertension, white matter hyperintensities, and concurrent impairments in mobility, cognition, and mood: the cardiovascular health study. Circulation. 2011;123:858–865.
   PubMed Web of Science ®Google Scholar
• Woods AJ, Cohen RA, Pahor M. Cognitive frailty: frontiers and challenges. J Nutr Health Aging. 2013;17:741–743.
   PubMed Web of Science ®Google Scholar
• Rothman MD, Leo-Summers L, Gill TM. Prognostic significance of potential frailty criteria. J Am Geriatr Soc. 2008;56:2211–2216.
   PubMed Web of Science ®Google Scholar
• Freiheit EA, Hogan DB, Eliasziw M, et al. Development of a frailty index for patients with coronary artery disease. J Am Geriatr Soc. 2010;58:1526–1531.
   PubMed Web of Science ®Google Scholar
• Chhetri JK, Zheng Z, Xu X, et al. The prevalence and incidence of frailty in Pre-diabetic and diabetic community dwelling older population: results from Beijing longitudinal study of aging II (BLSA-II). BMC Geriatr. 2017;17:47.
   PubMed Web of Science ®Google Scholar
• Castrejon-Perez RC, Aguilar-Salinas CA, Gutierrez-Robledo LM, et al. Frailty, diabetes, and the convergence of chronic disease in an age-related condition: a population-based nationwide cross-sectional analysis of the Mexican nutrition and health survey. Aging Clin Exp Res. 2018;30:935–941.
   PubMed Web of Science ®Google Scholar
• Park SW, Goodpaster BH, Strotmeyer ES, et al.; Health, Aging, and Body Composition Study. Accelerated loss of skeletal muscle strength in older adults with type 2 diabetes: the health, aging, and body composition study. Diabetes Care. 2007;30:1507–1512.
   PubMed Web of Science ®Google Scholar
• Aguilar-Navarro SG, Amieva H, Gutierrez-Robledo LM, et al. Frailty among Mexican community-dwelling elderly: a story told 11 years later. The Mexican health and aging study. Salud Pública Mex. 2015;57:S62–9.
   PubMed Web of Science ®Google Scholar
• Franceschi C, Campisi J. Chronic inflammation (inflammaging) and its potential contribution to age-associated diseases. J Gerontol A Biol Sci Med Sci. 2014;69(Suppl 1):S4–9.
   PubMed Web of Science ®Google Scholar
• Bouillon K, Kivimäki M, Hamer M, et al. Diabetes risk factors, diabetes risk algorithms, and the prediction of future frailty: the whitehall II prospective cohort study. J Am Med Dir Assoc. 2013; 14:e851.1–851.6. DOI:10.1016/j.jamda.2013.08.016
   Web of Science ®Google Scholar
• Zhang J, Chen C, Hua S, et al. An updated meta-analysis of cohort studies: diabetes and risk of Alzheimer’s disease. Diabet Res Clin Pract. 2017;124:41–47.
   PubMed Web of Science ®Google Scholar
• Ninomiya T. Diabetes mellitus and dementia. Curr Diab Rep. 2014;14:487.
   PubMed Web of Science ®Google Scholar
• Profenno LA, Porsteinsson AP, Faraone SV. Meta-analysis of alzheimer’s disease risk with obesity, diabetes, and related disorders. Biol Psychiatry. 2010;67:505–512.
   PubMed Web of Science ®Google Scholar
• Kloppenborg RP, van den Berg E, Kappelle LJ, et al. Diabetes and other vascular risk factors for dementia: which factor matters most? A systematic review. Eur J Pharmacol. 2008;585:97–108.
   PubMed Web of Science ®Google Scholar
• Whitmer RA, Biessels GJ, Quesenberry CP, et al. Type 1 diabetes and risk of dementia in late life: the Kaiser diabetes & cognitive aging study. Alzheimer’s Dementia. 2015;11(Suppl.):179–180.
   Google Scholar
• Davis WA, Zilkens RR, Starkstein SE, et al. Dementia onset, incidence and risk in type 2 diabetes: a matched cohort study with the fremantle diabetes study phase I. Diabetologia. 2017;60:89–97.
   PubMed Web of Science ®Google Scholar
• Meng XF, Yu JT, Wang HF, et al. Midlife vascular risk factors and the risk of Alzheimer’s disease: a systematic review and meta-analysis. J Alzheimers Dis. 2014;42:1295–1310.
   PubMed Web of Science ®Google Scholar
• Chireh B, Li M, D’Arcy C. Diabetes increases the risk of depression: a systematic review, meta-analysis and estimates of population attributable fractions based on prospective studies. Prev Med Rep. 2019;14:100822.
   PubMedGoogle Scholar
• de Jonge P, Roy JF, Saz P, et al. Prevalent and incident depression in community-dwelling elderly persons with diabetes mellitus: results from the ZARADEMP project. Diabetologia. 2006;49:2627–2633.
   PubMed Web of Science ®Google Scholar
• Maraldi C, Volpato S, Penninx BW, et al. Diabetes mellitus, glycemic control, and incident depressive symptoms among 70 to 79-year-old persons: the health, aging, and body composition study. Arch Intern Med. 2007;167:1137–1144.
   PubMedGoogle Scholar
• Almeida OP, McCaul K, Hankey GJ, et al. Duration of diabetes and its association with depression in later life: the Health in Men Study (HIMS). Maturitas. 2016;86:3–9.
   PubMed Web of Science ®Google Scholar
• Lohman M, Dumenci L, Mezuk B. Depression and frailty in late life: evidence for a common vulnerability. J Gerontol B Psychol Sci Soc Sci. 2016;71:630–640.
   PubMed Web of Science ®Google Scholar
• Vaughan L, Corbin AL, Goveas JS. Depression and frailty in later life: a systematic review. Clin Interv Aging. 2015;10:1947–1958.
   PubMed Web of Science ®Google Scholar
• Soysal P, Veronese N, Thompson T, et al. Relationship between depression and frailty in older adults: a systematic review and meta-analysis. Ageing Res Rev. 2017;36:78–87.
   PubMed Web of Science ®Google Scholar
• Godin J, Armstrong JJ, Rockwood K, et al. Dynamics of frailty and cognition after age 50: why it matters that cognitive decline is mostly seen in old age. J Alzheimers Dis. 2017;58:231–242.
   PubMed Web of Science ®Google Scholar
• Liu YC, Meguro K, Nakamura K, et al. Depression and dementia in old-old population: history of depression may be associated with dementia onset. The tome project. Front Aging Neurosci. 2017;9:335.
   PubMed Web of Science ®Google Scholar
• Li G, Wang LY, Shofer JB, et al. Temporal relationship between depression and dementia–findings from a large community-based 15 year follow-up study. Arch Gen Psychiatry. 2011;68:970–977.
   PubMed Web of Science ®Google Scholar
• Aichele S, Ghisletta P. Memory deficits precede increases in depressive symptoms in later adulthood. J Gerontol B Psychol Sci Soc Sci. 2018. DOI:10.1093/geronb/gbx183
   Web of Science ®Google Scholar
• Veronese N, Stubbs B, Fontana L, et al. Frailty is associated with an increased risk of incident type 2 diabetes in the elderly. J Am Med Dir Assoc. 2016;17:902–907.
   PubMed Web of Science ®Google Scholar
• Twig G, Gluzman I, Tirosh A, et al. Cognitive function and the risk for diabetes among young men. Diabetes Care. 2014;37:2982–2988.
   PubMed Web of Science ®Google Scholar
• Zhuang QS, Shen L, Ji HF. Quantitative assessment of the bidirectional relationships between diabetes and depression. Oncotarget. 2017;8:23389–23400.
   PubMedGoogle Scholar
• Panza F, Seripa D, Solfrizzi V, et al. Targeting cognitive frailty: clinical and neurobiological roadmap for a single complex phenotype. J Alzheimer’s Dis. 2015;47:793–813.
   PubMed Web of Science ®Google Scholar
• MacKenzie HT, Tugwell B, Rockwood K, et al. Frailty and diabetes in older hospitalized adults: the case for routine frailty assessment. Can J Diabetes. 2020;44:241–245.
   PubMed Web of Science ®Google Scholar
• Yanagita I, Fujihara Y, Eda T, et al. Low glycated hemoglobin level is associated with severity of frailty in Japanese elderly diabetes patients. J Diabetes Investig. 2018;9:419–425.
   PubMed Web of Science ®Google Scholar
• Morita T, Okuno T, Himeno T, et al. Glycemic control and disability-free survival in hypoglycemic agent-treated community-dwelling older patients with type 2 diabetes mellitus. Geriatr Gerontol Int. 2017;17:1858–1865.
   PubMed Web of Science ®Google Scholar
• Lin CL, Yu NC, Wu HC, et al. Risk factors associated with frailty in older adults with type 2 diabetes: a cross-sectional study. J Clin Nurs. 2022;31:967–974.
   PubMed Web of Science ®Google Scholar
• Kong L, Zhao H, Fan J, et al. Predictors of frailty among Chinese community-dwelling older adults with type 2 diabetes: a cross-sectional survey. BMJ Open. 2021;11:e041578.
   PubMedGoogle Scholar
• Fung E, Lui LT, Huang L, et al. Characterising frailty, metrics of continuous glucose monitoring, and mortality hazards in older adults with type 2 diabetes on insulin therapy (HARE): a prospective, observational cohort study. Lancet Healthy Longev. 2021;2:e724–35.
   PubMedGoogle Scholar
• Bilgin S, Aktas G, Kurtkulagi O, et al. Edmonton frail score is associated with diabetic control in elderly type 2 diabetic subjects. J Diabetes Metab Disord. 2020;19:511–514.
   PubMed Web of Science ®Google Scholar
• Hyde Z, Smith K, Flicker L, et al. hba1c is associated with frailty in a group of aboriginal Australians. J Frailty Aging. 2019;8:17–20.
   PubMed Web of Science ®Google Scholar
• Aguayo GA, Hulman A, Vaillant MT, et al. Prospective association among diabetes diagnosis, HbA1c, glycemia, and frailty trajectories in an elderly population. Diabetes Care. 2019;42:1903–1911.
   PubMed Web of Science ®Google Scholar
• García-Esquinas E, Graciani A, Guallar-Castillón P, et al. Diabetes and risk of frailty and its potential mechanisms: a prospective cohort study of older adults. J Am Med Dir Assoc. 2015;16:748–754.
   PubMed Web of Science ®Google Scholar
• Zaslavsky O, Walker RL, Crane PK, et al. Glucose levels and risk of frailty. J Gerontol A Biol Sci Med Sci. 2016;71:1223–1229.
   PubMed Web of Science ®Google Scholar
• Koh DH, Rho YJ, Lee SY, et al. Association between blood glucose control and subjective cognitive decline in korean patients with diabetes aged over 50 Years. Int J Environ Res Public Health. 2022;19:7267.
   PubMed Web of Science ®Google Scholar
• Dove A, Shang Y, Xu W, et al. The impact of diabetes on cognitive impairment and its progression to dementia. Alzheimers Dement. 2021;17:1769–1778.
   PubMed Web of Science ®Google Scholar
• Zheng B, Su B, Price G, et al. Glycemic control, diabetic complications, and risk of dementia in patients with diabetes: results from a large U.K. cohort study. Diabetes Care. 2021;44:1553–1556.
   Web of Science ®Google Scholar
• Jia Y, Liu R, Tang S, et al. Associations of the glycaemic control of diabetes with dementia and physical function in rural-dwelling older chinese adults: a population-based study. Clin Interv Aging. 2021;16:1503–1513.
   PubMed Web of Science ®Google Scholar
• Mimenza-Alvarado AJ, Jiménez-Castillo GA, Yeverino-Castro SG, et al. Effect of poor glycemic control in cognitive performance in the elderly with type 2 diabetes mellitus: the Mexican health and aging study. BMC Geriatr. 2020;20:424.
   PubMed Web of Science ®Google Scholar
• Rawlings AM, Sharrett AR, Albert MS, et al. The association of late-life diabetes status and hyperglycemia with incident mild cognitive impairment and dementia: the ARIC study. Diabetes Care. 2019;42:1248–1254.
   PubMed Web of Science ®Google Scholar
• Liu S, Lu Y, Cai X, et al. Glycemic control is related to cognitive dysfunction in elderly people with type 2 diabetes mellitus in a rural chinese population. Curr Alzheimer res. 2019;16:950–962.
   PubMed Web of Science ®Google Scholar
• Lacy ME, Gilsanz P, Karter AJ, et al. Long-term glycemic control and dementia risk in type 1 diabetes. Diabetes Care. 2018;41:2339–2345.
   PubMed Web of Science ®Google Scholar
• Zheng F, Yan L, Yang Z, et al. HbA1c, diabetes and cognitive decline: the English longitudinal study of ageing. Diabetologia. 2018;61:839–848.
   PubMed Web of Science ®Google Scholar
• Li TC, Yang CP, Tseng ST, et al. Visit-to-visit variations in fasting plasma glucose and HbA1c associated with an increased risk of alzheimer disease: taiwan diabetes study. Diabetes Care. 2017;40:1210–1217.
   PubMed Web of Science ®Google Scholar
• Gao Y, Xiao Y, Miao R, et al. The prevalence of mild cognitive impairment with type 2 diabetes mellitus among elderly people in China: a cross-sectional study. Arch Gerontol Geriatr. 2016;62:138–142.
   PubMed Web of Science ®Google Scholar
• Ravona-Springer R, Heymann A, Schmeidler J, et al. Trajectories in glycemic control over time are associated with cognitive performance in elderly subjects with type 2 diabetes. PLoS ONE. 2014;9:e97384.
   PubMed Web of Science ®Google Scholar
• West RK, Ravona-Springer R, Schmeidler J, et al. The association of duration of type 2 diabetes with cognitive performance is modulated by long-term glycemic control. Am J Geriatr Psychiatry. 2014;22:1055–1059.
   PubMed Web of Science ®Google Scholar
• Rawlings AM, Sharrett AR, Schneider AL, et al. Diabetes in midlife and cognitive change over 20 years: a cohort study. Ann Intern Med. 2014;161:785–793.
   PubMed Web of Science ®Google Scholar
• Tuligenga RH, Dugravot A, Tabák AG, et al. Midlife type 2 diabetes and poor glycaemic control as risk factors for cognitive decline in early old age: a post-hoc analysis of the Whitehall II cohort study. Lancet Diabetes Endocrinol. 2014;2:228–235.
   PubMed Web of Science ®Google Scholar
• Dinh Le T, Huy Duong H, Thi Nguyen L, et al. The relationship between depression and multifactorial control and microvascular complications in vietnamese with type 2 diabetes mellitus aged 30-60 years. Diabetes Metab Syndr Obes. 2022;15:1185–1195.
   PubMed Web of Science ®Google Scholar
• Hasanovic E, Trifunovic N, Dzambo I, et al. The association among glycemic control and depression symptoms in patients with type 2 diabetes. Mater Sociomed. 2020;32:177–182.
   PubMedGoogle Scholar
• Akimoto H, Tezuka K, Nishida Y, et al. Association between use of oral hypoglycemic agents in Japanese patients with type 2 diabetes mellitus and risk of depression: a retrospective cohort study. Pharmacol Res Perspect. 2019;7:e00536.
   PubMed Web of Science ®Google Scholar
• Azniza MR, Draman N, Siti Suhaila MY, et al. Depression and potential risk factors among the elderly with type 2 diabetes mellitus in Kedah, Malaysia. Med J Malaysia. 2019;74:103–108.
   PubMedGoogle Scholar
• Mansori K, Shiravand N, Shadmani FK, et al. Association between depression with glycemic control and its complications in type 2 diabetes. Diabet Metab Syndrome: Clin Res Rev. 2019;13:1555–1560.
   PubMed Web of Science ®Google Scholar
• Kim HJ, An SY, Han SJ, et al. The association of diabetes duration and glycemic control with depression in elderly men with type 2 diabetes mellitus. J Res Med Sci. 2019;24:17.
   PubMed Web of Science ®Google Scholar
• Mattei J, Falcon LM, Tucker KI. Depressive symptoms and glycemic control among puerto rican adults with diabetes. Diabetes. 2018;67(Supplement_1):1596.
   Google Scholar
• Akpalu J, Yorke E, Ainuson-Quampah J, et al. Depression and glycaemic control among type 2 diabetes patients: a cross-sectional study in a tertiary healthcare facility in Ghana. BMC Psychiatry. 2018;357. DOI:10.1186/s12888-018-1933-2.
   Google Scholar
• Ravona-Springer R, Heymann A, Schmeidler J, et al. Hemoglobin A1c variability predicts symptoms of depression in elderly individuals with type 2 diabetes. Diabetes Care. 2017;40:1187–1193.
   PubMed Web of Science ®Google Scholar
• Sun N, Lou P, Shang Y, et al. Prevalence and determinants of depressive and anxiety symptoms in adults with type 2 diabetes in China: a cross-sectional study. BMJ Open. 2016;6:e012540.
   PubMed Web of Science ®Google Scholar
• Abdelhafiz AH, McNicholas E, Sinclair AJ. Hypoglycemia, frailty and dementia in older people with diabetes: reciprocal relations and clinical implications. J Diabetes Complications. 2016;30:1548–1554.
   PubMed Web of Science ®Google Scholar
• Phielix E, Schrauwen-Hinderling VB, Mensink M, et al. Lower intrinsic ADP-stimulated mitochondrial respiration underlies in vivo mitochondrial dysfunction in muscle of male type 2 diabetic patients. Diabetes. 2008;57:2943–2949.
   PubMed Web of Science ®Google Scholar
• Park SW, Goodpaster BH, Strotmeyer ES, et al. Accelerated loss of skeletal muscle strength in older adults with type 2 diabetes: the health, aging, and body composition study. Diabetes Care. 2007;30:1507–1512.
   PubMed Web of Science ®Google Scholar
• Park SW, Goodpaster BH, Lee JS, et al. Excessive loss of skeletal muscle mass in older adults with type 2 diabetes. Diabetes Care. 2009;32:1993–1997.
   PubMed Web of Science ®Google Scholar
• Kim KS, Park KS, Kim MJ, et al. Type 2 diabetes is associated with low muscle mass in older adults. Geriatr Gerontol Int. 2014;14(Suppl 1):115–121.
   PubMedGoogle Scholar
• Yoon JW, Ha YC, Kim KM, et al. Hyperglycemia is associated with impaired muscle quality in older men with diabetes: the Korean longitudinal study on health and aging. Diabetes Metab J. 2016;40:140–146.
   PubMed Web of Science ®Google Scholar
• Assar ME, Angulo J, Rodriguez-Manas L. Diabetes and ageing- induced vascular inflammation. J Physiol. 2016;594:2125–2146.
   PubMed Web of Science ®Google Scholar
• Abdelhafiz AH, Sinclair AJ. Metabolic phenotypes explain the relationship between dysglycaemia and frailty in older people with type 2 diabetes. J Diabetes Complications. 2022;36:108144.
   PubMed Web of Science ®Google Scholar
• Sinclair AJ, Abdelhafiz AH. Metabolic impact of frailty changes diabetes trajectory. Metabolites. 2023 16;13:295. doi: 10.3390/metabo13020295
   PubMed Web of Science ®Google Scholar
• Gottesman RF, Schneider AL, Zhou Y, et al. Association between midlife vascular risk factors and estimated brain amyloid deposition. JAMA. 2017;317:1443–1450.
   PubMed Web of Science ®Google Scholar
• Monnier L, Mas E, Ginet C, et al. Activation of oxidative stress by acute glucose fluctuations compared with sustained chronic hyperglycemia in patients with type 2 diabetes. JAMA. 2006;295:1681–1687.
   PubMed Web of Science ®Google Scholar
• Ceriello A, Esposito K, Piconi L, et al. Oscillating glucose is more deleterious to endothelial function and oxidative stress than mean glucose in normal and type 2 diabetic patients. Diabetes. 2008;57:1349–1354.
   PubMed Web of Science ®Google Scholar
• Wheeler MJ, Dempsey PC, Grace MS, et al. Sedentary behavior as a risk factor for cognitive decline? A focus on the influence of glycemic control in brain health. Alzheimers. 2017;Dement (N Y(3):291–300.
   Google Scholar
• Moheet A, Mangia S, Seaquist ER. Impact of diabetes on cognitive function and brain structure. Ann N Y Acad Sci. 2015;1353:60–71.
   PubMed Web of Science ®Google Scholar
• Schimming C, Luo X, Zhang C, et al. Cognitive performance of older adults in a specialized diabetes clinic. J Diabetes. 2017;9:929–935.
   PubMed Web of Science ®Google Scholar
• Lalithambika CV, Arun CS, Saraswathy LA, et al. Cognitive impairment and its association with glycemic control in type 2 diabetes mellitus patients. Indian J Endocr Metab. 2019;23:353–356.
   PubMedGoogle Scholar
• Launer LJ, Miller ME, Williamson JD, et al. Effects of intensive glucose lowering on brain structure and function in people with type 2 diabetes (ACCORD MIND): a randomised open-label substudy. Lancet Neurol. 2011;10:969–977.
   PubMed Web of Science ®Google Scholar
• Koekkoek PS, Ruis C, van den Donk M, et al. Intensive multifactorial treatment and cognitive functioning in screen-detected type 2 diabetes—the ADDITION-Netherlands study: a cluster-randomized trial. J Neurol Sci. 2012;314:71–77.
   PubMed Web of Science ®Google Scholar
• Luchsinger JA, Palmas W, Teresi JA, et al. Improved diabetes control in the elderly delays global cognitive decline. J Nutr Health Aging. 2011;15:445–449.
   PubMed Web of Science ®Google Scholar
• Mezuk B, Eaton WW, Albrecht S, et al. Depression and type 2 diabetes over the lifespan: a meta-analysis. Diabetes Care. 2008;31:2383–2390.
   PubMed Web of Science ®Google Scholar
• Golden SH, Lazo M, Carnethon M, et al. Examining a bidirectional association between depressive symptoms and diabetes. JAMA. 2008;299:2751–2759.
   PubMed Web of Science ®Google Scholar
• Golden SH. A review of the evidence for a neuroendocrine link between stress, depression and diabetes mellitus. Curr Diabetes Rev. 2007;3:252–259.
   PubMedGoogle Scholar
• Nolen-Hoeksema S. Gender differences in depression. Curr Dir Psychol Sci. 2001;10:173–176.
   Web of Science ®Google Scholar
• Frech A, Williams K. Depression and the psychological benefits of entering marriage. J Health Soc Behav. 2007;48:149–163.
   PubMed Web of Science ®Google Scholar
• Writing Team for the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Research Group. Effect of intensive therapy on the microvascular complications of type 1 diabetes mellitus. JAMA. 2002;287:2563–2569.
   PubMed Web of Science ®Google Scholar
• Manschot SM, Biessels GJ, de Valk H, et al.; Utrecht Diabetic Encephalopathy Study Group. Metabolic and vascular determinants of impaired cognitive performance and abnormalities on brain magnetic resonance imaging in patients with type 2 diabetes. Diabetologia. 2007;50:2388–2397.
   PubMed Web of Science ®Google Scholar
• Stratton IM, Adler AI, Neil HA, et al. Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study. BMJ. 2000;321:405–412.
   PubMed Web of Science ®Google Scholar
• Santos M, Kövari E, Hof PR, et al. The impact of vascular burden on late-life depression. Brain Res Brain Res Rev. 2009;62:19–32.
   Google Scholar
• Marano CM, Workman CI, Lyman CH, et al. The relationship between fasting serum glucose and cerebral glucose metabolism in late-life depression and normal aging. Psychiatry Res. 2014;222:84–90.
   PubMed Web of Science ®Google Scholar
• Abdelhafiz AH, Peters S, Sinclair AJ. Low glycaemic state increases risk of frailty and functional decline in older people with type 2 diabetes mellitus - Evidence from a systematic review. Diabet Res Clin Pract. 2021;181:109085.
   PubMed Web of Science ®Google Scholar
• Abdelhafiz AH, Sinclair AJ. Cardio-renal protection in older people with diabetes with frailty and medical comorbidities-A focus on the new hypoglycaemic therapy. J Diabetes Complications. 2020;34:107639.
   PubMed Web of Science ®Google Scholar
• Monti G, Gomes Moreira D, Richner M, et al. GLP-1 receptor agonists in neurodegeneration: neurovascular unit in the spotlight. Cells 2022; 11: p. 2023. doi: 10.3390/cells11132023.
   Google Scholar